Outcome and safety of single-dose docetaxel-augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience.
来源：PubMed发布日期：2026-03-16作者：Ebert N, Rosar F, Burgard C, Bartholomä M, Maus S0 次点击